Is It Time to Move Beyond Graft-Versus-Host Disease-Free, Relapse-Free Survival as a Primary End Point in Clinical Trials for Hematopoietic Cell Transplantation?

21 Jan 20264 min read0 viewsJournal Feed

GIST

Journal of Clinical Oncology, Volume 44, Issue 15 , Page 1389-1394, May 2026.

Clinical Editorial

Summary

Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 21 Jan 2026. The item focuses on Is It Time to Move Beyond Graft-Versus-Host Disease-Free, Relapse-Free Survival as a Primary End Point in Clinical Trials for Hematopoietic Cell Transplantation?. Open the detail page to review the full original feed content.